e.g. mhealth
Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Dermatology
- 1 JMIR Infodemiology
- 1 JMIR Public Health and Surveillance
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Moreover, most countries have used various vaccine brands (eg, Moderna, Pfizer, Astra Zeneca, and Jassen), each with different use guidelines and safety and efficacy profiles [14,15]. However, there have been few in-depth studies on topics and sentiments focused on AEs, particularly over long periods after rollout.
Korea reported that 70% of its population had already been fully vaccinated within 8 months of the start of the vaccination drive on February 26, 2021 [16].
J Med Internet Res 2023;25:e42623
Download Citation: END BibTex RIS
The Moderna messenger RNA (m RNA) COVID-19 vaccine was granted emergency use authorization within the United States in December 2020. As vaccination administration expands, a growing body of evidence becomes available, allowing for a greater understanding of a novel vaccine’s adverse effects. A recent registry-based study by Mc Mahon et al [1] documented 414 unique cases of cutaneous reactions after COVID-19 vaccination, with 343 (83%) occurring in patients who received the Moderna m RNA vaccine.
JMIR Dermatol 2022;5(4):e41739
Download Citation: END BibTex RIS
By late February 2021, the Pfizer-Bio NTech (Pfizer), Moderna, and Johnson & Johnson (J&J/Janssen) vaccines were all approved for emergency use authorization. The Pfizer and Moderna vaccination drives started much earlier, in late December (Figures S2 and S3 in Multimedia Appendix 1), as compared to that of the Janssen vaccines, which also saw a stall in vaccine rates in mid-April (Figure S4 in Multimedia Appendix 1).
JMIR Public Health Surveill 2022;8(11):e38898
Download Citation: END BibTex RIS
Marcec and Likic [13] applied lexicon-based sentiment analysis to English tweets mentioning Astra Zeneca, Pfizer, and Moderna and found that the sentiment for Pfizer and Moderna was generally more positive than that for Astra Zeneca. Sattar and Arifuzzaman [14] analyzed tweets related to public sentiment about COVID-19 vaccination awareness and found strong positive sentiments despite the side effects of the vaccine.
JMIR Infodemiology 2022;2(2):e39504
Download Citation: END BibTex RIS